Valuation: Emcure Pharmaceuticals Limited

Market Cap 343B 3.59B 3.14B 2.9B 2.68B 5.09B 5.18B 34.77B 13.53B 168B 13.48B 13.19B 584B P/E 2026
32.7x
P/E 2027 * 29.8x
Enterprise Value 350B 3.66B 3.2B 2.96B 2.73B 5.19B 5.28B 35.45B 13.79B 172B 13.75B 13.45B 595B EV / Sales 2026
3.33x
EV / Sales 2027 * 3.33x
Free-Float
18.3%
Yield 2026
0.23%
Yield 2027 * 0.21%
1 day-1.86%
1 week-1.45%
Current month-1.45%
1 month+2.99%
3 months+16.36%
6 months+18.47%
Current year+32.60%
1 week 1,789.8
Extreme 1789.8
1,864.8
1 month 1,679
Extreme 1679
1,944
Current year 1,381
Extreme 1381
1,944
1 year 1,237
Extreme 1237
1,944
3 years 889
Extreme 889
1,944
5 years 889
Extreme 889
1,944
10 years 889
Extreme 889
1,944
Manager TitleAgeSince
Chief Executive Officer 75 1981-04-15
Director of Finance/CFO - 2003-09-30
Compliance Officer - 2026-02-03
Director TitleAgeSince
Director/Board Member 72 2001-07-22
Chairman 69 -
Director/Board Member 75 1981-04-15
Change 5-day change 1-year change 3-year change Capi.($)
-1.86%-1.45%+45.55% - 3.68B
-1.60%+1.37%+57.31%+168.94% 1,102B
-1.44%+3.71%+69.64%+65.40% 643B
-0.75%+0.44%+34.70%+86.52% 450B
-1.35%+0.63%+30.26%+26.28% 336B
-0.86%+0.99%+39.36%+40.85% 298B
-0.71%-0.54%+28.98%+48.27% 288B
-1.31%+2.72%-26.76%-39.82% 222B
-0.03%+1.62%+25.62%+68.30% 199B
-0.40%+7.50%+21.51%+82.50% 169B
Average -0.82%+1.97%+32.62%+60.81% 370.97B
Weighted average by Cap. -0.38%+2.13%+42.26%+86.55%

Financials

2026 2027 *
Net sales 91.56B 958M 839M 775M 715M 1.36B 1.38B 9.28B 3.61B 44.89B 3.6B 3.52B 156B 104B 1.09B 956M 883M 816M 1.55B 1.58B 10.58B 4.12B 51.19B 4.1B 4.01B 178B
Net income 9.81B 103M 89.86M 83M 76.65M 145M 148M 994M 387M 4.81B 386M 377M 16.69B 11.5B 120M 105M 97.25M 89.82M 170M 174M 1.17B 453M 5.64B 452M 442M 19.56B
Net Debt 6.75B 70.64M 61.82M 57.1M 52.73M 100M 102M 684M 266M 3.31B 265M 259M 11.48B 4.56B 47.77M 41.81M 38.62M 35.66M 67.68M 68.94M 463M 180M 2.24B 179M 175M 7.77B
Logo Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several major therapeutic areas. It offers a range of products and services under formulations, biologics and Active Pharmaceutical Ingredient (APIs). It operates across a wide scope of areas, including Gynecology, Cardiovascular, HIV Antivirals, VMN (Vitamins, Minerals & Nutrients), Pain/Analgesics, Nephrology, Oncology, Anti-Infective, Respiratory, CNS. Its brands include Orofer XT and Pause (Gynecological), Proxym (pain), Tenectase (CNS), Vylda (diabetology), Vitanova (VMN). Its API products include S-Amlodipine, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (Tenecteplase), Vintor (Erythropoietin), TENECTASE (Tenecteplase). It has developed two platforms: Mammalian and Microbial.
Employees
6,731
Date Price Change Volume
26-07-08 ₹1,809.30 -1.86% 130,096
26-07-07 ₹1,843.50 +0.46% 124,180
26-07-06 ₹1,835.00 -0.22% 121,333
26-07-03 ₹1,839.10 -0.94% 69,426
26-07-02 ₹1,856.50 +1.40% 183,639
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,809.30INR
Average target price
1,913.50INR
Spread / Average Target
+5.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMCURE Stock